Procter & Gamble said on Thursday it would cut 7,000 jobs, or about 15% of its non-manufacturing roles globally over the next two years as part of its non-core restructuring program.
The American consumer giant also said it would trim its portfolio of brands.
The latest trading day saw Procter & Gamble (PG) settling at $165.95, representing a -0.54% change from its previous close.
Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.
PG faces near-term headwinds related to the market issues in Greater China, geopolitical tensions and financial impacts of currency volatility.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Procter & Gamble's FQ3 2025 earnings report shows declines in key segments. I believe such earnings pressure largely came from headwinds from trade disputes and persisting inflation. I further expect these headwinds to continue and continue to confine PG stock to be range bound.
I reiterate my 'Buy' rating on Procter & Gamble with a fair value of $177 per share, citing its defensive nature amid economic uncertainties. Procter & Gamble reported 1% organic revenue and core EPS growth, reflecting weak US consumer consumption but stable beauty, grooming, and healthcare segments. The company faces near-term tariff headwinds but is adjusting its global supply chain; FY25 guidance implies weak consumption and some financial impact from tariffs.
PG matches earnings estimates in third-quarter fiscal 2025, while sales remain soft. Organic sales grew year over year, driven by the rise in pricing.